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ABSTRACT OF THE DISSERTATION 
 
 
The Role of the Clock Gene Bmal1 in Female Fertility and Parturition 
 
 
By 
 
Christine Kathleen Ratajczak 
 
Doctor of Philosophy in Biology and Biomedical Sciences 
 
(Molecular Cell Biology) 
 
Washington University in St. Louis, 2010 
 
Professors Louis J. Muglia and Kelle H. Moley, Chairpersons 
 
 
Successful reproduction is essential for survival of species. For humans, reproductive 
problems can cause large emotional and medical burdens. Evidence in both humans and 
rodents indicates that circadian rhythmicity is important for supporting reproductive 
function.  A molecular clock orchestrates circadian rhythmicity. Impairment in fertility 
and parturition are observed in female mice expressing a mutant form of Clock, 
suggesting critical roles for clock genes in reproduction. Since the clock gene Bmal1, but 
not Clock, is necessary for the generation of circadian rhythmicity, exploring the role of 
Bmal1 in reproduction may yield a better understanding of the importance of the 
molecular clock in this process. We characterized the reproductive phenotype of Bmal1-/- 
females. These females were infertile, and our data suggests that implantation failure due 
to impaired steroidogenesis is a major contributor to this infertility. Expression of Bmal1 
and other clock genes has been demonstrated in such tissues important for the early 
stages of the reproductive process as the ovary, oviduct, GnRH neurons, and non-gravid 
uterus. However, the expression of clock genes in tissues involved in the later stages of 
 viii 
gestation has been largely unexplored. We determined that Bmal1 and other core clock 
genes are expressed in the gravid uterus, placenta, and fetal membranes of wild-type mice 
during the last third of gestation. Many of these genes were expressed in a rhythmic 
fashion throughout the circadian day suggesting the presence of operating peripheral 
molecular clocks in these tissues. The study of the role of Bmal1 in the late stages of the 
reproductive process is complicated by the infertility experienced by Bmal1-/- mice. To 
circumvent the problem of infertility and to examine the role of peripheral tissue Bmal1 
expression in late gestation, we generated conditional Bmal1 knockout mice. These mice 
were used in concert with Telokin-Cre mice to disrupt Bmal1 specifically in the 
myometrium, the muscle portion of the uterus. Myometrial Bmal1 disruption was found 
to result in a disregulation of labor timing and altered expression of contractile-associated 
proteins. Results presented here demonstrate an importance of the core clock gene Bmal1 
in both early and late stages of the reproductive process. These studies may lead to a 
better understanding of the roles of clock genes in supporting normal reproductive 
function in women.  
 
                         Christine K. Ratajczak 
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CHAPTER ONE 
 
 
 
 
Introduction 
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Successful reproduction is essential for survival of species. For humans, reproductive 
problems can cause large emotional and medical burdens. Infertility affects 8% of 
females aged 19-26 years and 18% of females aged 35 to 39 years (1). In many cases, 
assisted reproductive technologies have given new choices to couples experiencing 
infertility. However, the success rates of such procedures are somewhat disappointing, 
with 44% of procedures resulting in a pregnancy and 36% resulting in a live birth (2). 
Furthermore, such procedures come at a great financial cost. In the United States, the cost 
per live birth using assisted reproductive technologies is estimated at $41,132 (3). 
Reproductive challenges are also often faced at the end of pregnancy in the form of 
preterm birth. In the United States, 12.7% of births are preterm (4). In recent decades, the 
rate of preterm birth has increased (5). Preterm birth is associated with both increased 
risk of neonatal mortality and chronic sequelae such as respiratory illness, cerebral palsy, 
and vision and hearing impairment (6), making it a major public health concern. Given 
the importance of the reproductive process and the problems associated with 
malfunctions therein, it is necessary to gain a better understanding of the molecular basis 
of how pregnancies are established, maintained, and resolved.  
Several lines of evidence indicate an importance of circadian rhythmicity in 
reproduction. In women, disruption of circadian rhythmicity may lead to reproductive 
difficulties. Studies of female shiftworkers demonstrate that this population of women 
has an increased incidence of altered menstrual function (7), subfertility (8), low birth 
weight babies (9), and preterm labor (9).  Furthermore, mammalian species exhibit a 
tendency to begin labor and deliver at a characteristic time of day. Epidemiological data 
from two separate studies indicate that humans tend to labor in the early morning hours 
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(10, 11). Mice deliver in the dark phase of a light:dark cycle, while rats and hamsters 
deliver during the light phase. Little is known however about how rhythmicity may be 
affecting reproduction. The work embodied in this thesis seeks to elucidate the 
mechanistic basis for circadian effects on reproduction.  
The Molecular Clock 
Circadian rhythmicity is generated by the oscillating expression levels of clock genes 
(12) (Figure 1). Transcriptional feedback loops help drive these oscillations. The 
CLOCK:BMAL1 heterodimer induces transcription of genes including the Period(Per) 
and Cryptochrome(Cry) genes by binding to E-box enhancers. PER and CRY complex 
and inhibit the ability of the CLOCK:BMAL1 heterodimer to bind E-boxes, thus shutting 
down their own transcription (12). Post-translational modification, notably 
phosphorylation, of clock proteins also plays a role in driving the molecular clock (12). 
The clock genes are expressed not only in the suprachiasmatic nucleus (SCN), which is 
regarded as the masterclock of the organism, but also in numerous other peripheral 
tissues that have been examined.  
 Rhythmic expression of core clock genes has been noted in tissues important for 
fertility including the ovary (13), oviduct (14), and uterus (15) of non-gravid female 
rodents. Rhythmic expression of clock genes in testis has been reported (16), but other 
studies indicate that this tissue is nonrhythmic (17, 18). One study examining clock gene 
expression in Leydig cells of the testis found rhythmic expression of Bmal1 specifically 
in this cell type (19). Additionally, rhythmic clock gene expression has been reported for 
epididymis and prostate, while the seminal vesicle is reportedly nonrhythmic (20). 
 Little information is available regarding the existence of fetal peripheral clocks. 
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Previous studies on rhythmic clock gene expression in the fetus have focused on the fetal 
SCN. The mouse fetal SCN develops between days 12 and 15 of gestation (21), and 
exhibits circadian oscillation of Per1 transcript by day 17 of gestation (22). One study 
using in vivo bioluminescent imaging of pregnant Per1::luciferase rats indicated 
expression of Per1 in the fetus by day 10 of gestation and diurnal fluctuation in the 
expression of Per1 by day 12 (23). However, in this study it was not possible to 
determine the fetal tissues that contributed to the gene expression observed. 
The Molecular Clock and Reproduction: Rodent Studies 
SCN-lesioning studies in rats support an importance of circadian rhythmicity for normal 
reproductive phenotype. Lesions of the SCN result in a loss of rhythmicity of locomotor 
activity and drinking behavior (24). SCN-lesioned female rats manifest irregular estrus 
cycles (25), inhibition of the preovulatory surge in luteinizing hormone (LH) (26), and 
failed ovulation (27). In addition, lesioning of the SCN on day 19 of gestation in pregnant 
female rats has been shown to change the circadian gating of parturition. Rats normally 
deliver during a 36 hour time window with two peak frequencies of parturition on days 
21 and 22 of gestation. These peaks occur 24 hours apart. However, lesioned rats show 
one peak in parturition frequency at a time in between those of the two normal peaks 
(28). These studies indicate the importance of the central molecular clock in supporting 
female fertility and dictating the normal timing of birth. 
Characterization of genetically-altered mice with clock gene deficiencies have 
also indicated the importance of the molecular clock for normal female reproductive 
phenotype. Of these genetically-altered mice, reproductive phenotype has been most 
extensively described in the ClockΔ19/ ClockΔ19 females. ClockΔ19/ ClockΔ19 mice have a 51 
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amino acid deletion in the transcriptional activation domain of Clock. The mutant protein 
maintains its ability to heterodimerize with BMAL1, but is unable to activate transciption 
at E-box elements (29, 30). This mouse strain exhibits a prolonged circadian period 
(~27.3 hours) and a breakdown of rhythmicity in constant darkness (31). The ClockΔ19/ 
ClockΔ19 mice have irregular estrus (15, 32, 33), a lack of responsiveness to 
superovulation (34), and an absence of the preovulatory LH surge (33). Additionally, 
transient expression of the ClockΔ19 protein in GT1-7 cells, a mouse hypothalamic cell 
line, causes a change in the pattern of gonadotropin releasing hormone (GnRH) secretion 
(32). Decreased fertility of the ClockΔ19/ ClockΔ19 mice has been reported by several 
groups (32, 34, 35) but refuted in one published report (15). Further aberrant phenotypes 
have been reported after the establishment of pregnancy in ClockΔ19/ ClockΔ19 mice. A 
high incidence of midgestational fetal resorption has been noted for pregnant ClockΔ19/ 
ClockΔ19 dams (33). In addition, increased rates of prolonged, but nonproductive 
parturition have been noted for laboring ClockΔ19/ ClockΔ19 females (15, 33). Differing 
parturition phenotypes between SCN lesioned and ClockΔ19/ ClockΔ19 rodents indicate the 
possibility for different roles of the molecular clock in the SCN versus peripheral tissues 
in supporting normal labor.  
Reproductive abnormalities of Bmal1 null female mice have been commented on, 
but have not been analyzed to the depth that they have in ClockΔ19/ ClockΔ19 females. 
Bmal1 null mice have their basic helix-loop-helix (bHLH) domain disrupted with a 
neomycin cassette. The bHLH domain is important for heterodimerization of BMAL1 
and CLOCK as well as binding of the heterodimer to DNA. The Bmal1 null mouse 
exhibits a loss of circadian rhythmicity in constant darkness and an abrogation of 
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rhythmicity of fellow clock genes mPer1 and mPer2 (36). Bmal1 null females have been 
noted to have a delayed onset of puberty (37), but reports as to the regularity of their 
estrus cycle are conflicting (37, 38). Bmal1 null females are reportedly infertile (19, 38). 
However, embryos have been noted to be present in the reproductive tract of Bmal1 null 
females at day 3.5 of gestation that have been superovulated and mated (37). 
The reproductive phenotype of the Bmal1 null male has been more thoroughly 
explored. Bmal1 null males are infertile (19). These males have low levels of serum 
testosterone and expression of genes involved in steroidogenesis is reduced in the testis 
(19). Of the steroidogenesis related genes found to be downregulated in the Bmal1 null 
testis, the greatest reduction is in steroidogenic acute regulatory protein (StAR) (19). This 
enzyme regulates the rate-limiting step of steroidogenesis. Interestingly, StAR expression 
is reduced in other steroidogenic tissues of Bmal1 null mice (19). In addition, BMAL1 
was found to increase StAR transcription in a Leydig cell line, indicating a direct effect of 
BMAL1 on StAR expression (19). 
Roles of Peripheral Clocks 
Although the SCN largely orchestrates circadian rhythmcity and entrains the molecular 
clocks present in other tissues (12), the importance of the peripheral clocks is emerging. 
Some exogenous factors such as stress (39) and food availability (40) have been shown to 
alter rhythmicity in peripheral clocks independent of the SCN.  Furthermore, peripheral 
clocks have been identified as having some roles independent of the central clock in the 
SCN. A study by McDearmon and colleagues demonstrated differential roles of the clock 
gene Bmal1 in the SCN and muscle (41). In addition to losing circadian rhythmicity in 
constant darkness, Bmal1 null mice have decreased activity levels and body weight (41). 
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When Bmal1 expression is restored specifically in the SCN of Bmal1 null mice, circadian 
rhythmicity in constant darkness is reinstated, but activity levels and body weight are still 
below normal (41). Conversely, when Bmal1 expression is restored specifically in muscle 
of Bmal1 null mice, normal activity levels and body weight are observed, but the animals 
are arrhythmic in constant darkness (41). The role of the molecular clock in the retina has 
also been explored (42). The retinas of Bmal1 null mice have an abnormal electrical and 
transcriptional response to light. Using a conditional Bmal1 null mouse, Storch and 
colleagues demonstrated that mice deficient for Bmal1 in retina only had the same 
aberrant retinal response to light as conventional knockout animals (42). This indicates a 
discrete physiological role for the molecular clock in the retina.  
Mice As Model Organisms 
Because most human genes have a murine counterpart, much can be learned about human 
development and disease by studying the mouse. Gene-targeting by homologous 
recombination in embryonic stem cells has facilitated the deletion of specific genes of 
interest in mice. The conventional knockout mice produced using this technology have 
been invaluable in elucidating the function of many genes. However, in some cases an 
early developmental role or multiple adult roles of a gene make it difficult or impossible 
to study all functions of a gene of interest using the conventional knockout system. In 
such cases, it is often beneficial to inactivate a gene of interest in a tissue-specific 
manner. The bacteriophage P1-derived Cre-LoxP system has been used for this purpose. 
Cre recombinase induces site-specific genetic recombination at 34 base pair loxP sites. 
LoxP sites are introduced around areas of a gene necessary for functionality using 
homologous recombination into embryonic stem cells, resulting in a “floxed” allele. Mice 
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with a floxed allele are then bred to transgenic mice with Cre under the control of a tissue 
or cell-type specific promoter. In progeny conditional knockout mice, the gene of interest 
is inactivated only in the targeted area. 
Mice have been used extensively to examine both early and late stages of 
reproduction. Convenient for reproductive studies, mice have a short duration of 
gestation. Although the mouse has many advantages as a research tool, its relevance for 
increasing the understanding of human parturition has been questioned due to known 
differences in the parturition cascades of mice and humans. In both species, high levels of 
progesterone are produced during pregnancy. Progesterone is necessary for implantation 
and for maintaining uterine quiescence during gestation. In the mouse, the corpora lutea 
are responsible for steroid hormone production throughout gestation, while in humans 
this responsibility shifts from the corpora lutea to the placenta as gestation progresses. At 
the onset of normal murine parturition, prostaglandins trigger luteolysis, the structural 
and functional degradation of the corpora lutea, and a decrease in circulating 
progesterone (43) (Fig. 2). Humans exhibit no such progesterone withdrawal at term (44). 
A functional progesterone withdrawal, mediated by a decrease in the progesterone 
receptor’s transcriptional activity, may be a part of normal human parturition (45). Other 
important components of the parturition cascade are known to be shared between mice 
and humans. For instance, in each species transcript for contractile associated proteins 
(CAPs), such as oxytocin receptor (Oxtr), prostaglandin F2α receptor (FP), and 
connexin43 (Cx43), is upregulated in the uterus at term (46-49). 
In the studies described herein, conventional and conditional Bmal1 knockout 
mice are used to assess the importance of clock genes in female reproductive function. 
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Animals deficient in Bmal1 were chosen for these studies because of the robust circadian 
phenotype of the Bmal1 conventional knockout mouse. The Bmal1 null mouse loses 
circadian rhythmicity in constant darkness (50), indicating that Bmal1 is necessary for 
circadian function. While the ClockΔ19/ ClockΔ19 mouse, whose reproductive phenotype 
has been extensively characterized, exhibits a prolonged circadian period (~27.3 hours) 
and a breakdown of rhythmicity in constant darkness (31), the Clock conventional 
knockout mouse has a more subtle circadian phenotype. In the Clock null mouse, exons 5 
and 6 which contain the bHLH domain are deleted. In these mice, no CLOCK protein is 
detectable via an antibody to the C-terminus. This Clock knockout mouse exhibits a 
slightly shorter circadian period than wild type controls but maintenance of circadian 
rhythmicity in constant darkness. This finding indicates that CLOCK is not necessary for 
circadian function (51). Therefore, the study of mice deficient in Bmal1 may yield a 
better understanding of the role of the molecular clock and circadian rhythmicity in 
reproduction than previous studies using animals with altered Clock.  
The studies depicted in this thesis use conventional Bmal1 null mice to examine 
the impact of this gene on the early stages of the reproductive process. Because Bmal1 
null females are infertile, conditional Bmal1 knockout mice are used to examine the role 
of Bmal1 in the later stages of the reproductive process. Through the use of conditional 
knockout mice, we also aim to better understand the specific roles of peripheral tissue 
Bmal1 in the reproductive process. 
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Figure 1. Molecular clock. CLOCK/BMAL1 drives transcription of the 
Period (Per) and Cryptocrome (Cry) genes by binding E-box enhancers. 
The PER/CRY complex blocks induction of transcription by 
CLOCK/BMAL1. 
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Figure 2. Parturition cascade in mice. Membrane phospholipids are converted to 
prostaglandin F
2α
, (PGF
2α
) by the sequential action of cytoplasmic phospholipase A2 
(cPLA2), cyclooxygenase-1 (COX-1), and PGF synthase. Action of PGF2α on PGF2α 
receptors (FP) in the corpus luteum results in involution of this organ and a decrease in 
serum progesterone levels. Decreased progesterone levels induce expression of 
contractile associated proteins (CAPs) like connexin43 (Cx43), oxytocin receptor (Oxtr), 
and FP in the myometrium. Uterine contractility is increased and labor proceeds.
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Abstract 
 
Evidence in humans and rodents suggests that normal circadian rhythmicity is important 
for supporting reproductive function. A molecular clock underlies circadian rhythmicity. 
Impaired fertility is observed in some genetically altered mice with deficiencies in genes 
of the molecular clock, suggesting a critical role for these genes in reproduction. Here, 
we systematically characterize the reproductive phenotype of females deficient in the 
clock gene Bmal1. Bmal1-/- females are infertile. They exhibit progression through the 
estrus cycle, although these cycles are prolonged. Normal follicular development occurs 
in Bmal1-/- females, and healthy embryos of the expected developmental stage are found 
in the reproductive tract of Bmal1-/- females 3.5 days after mating to wild-type males. 
However, serum progesterone levels are significantly lower in Bmal1-/- versus Bmal1+/+ 
females on day 3.5 of gestation. Low progesterone levels in Bmal1-/- females are 
accompanied by decreased expression of steroidogenic acute regulatory protein (StAR) in 
corpora lutea of Bmal1-/- versus Bmal1+/+ females. While implantation of embryos is not 
observed in untreated or vehicle treated Bmal1-/- females, exogenous administration of 
progesterone to Bmal1-/- females is able to reinstitute implantation. This data suggests 
that implantation failure due to impaired steroidogenesis causes infertility of Bmal1-/- 
females. 
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Introduction  
Infertility affects 8% of females aged 19-26 and 18% of females aged 35-39 (1). Given 
these statistics, a greater understanding of normal fertility and causes of infertility is 
warranted. Disruption of circadian rhythmicity may lead to reproductive difficulties in 
women. Altered menstrual function (2), subfertility (3), and increased incidence of 
miscarriage (4) have been reported in female shiftworkers. Circadian rhythmicity is 
driven by a group of core clock genes, including Clock, Bmal1, Per1/2, and Cry1/2 (5). 
These genes are expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus, 
which is considered the masterclock of the organism, as well as in many peripheral 
tissues. Expression of clock genes has been noted in the uterus (6), oviduct (7), ovary (8), 
and GnRH neurons (9), indicating a potential role for these genes in supporting normal 
reproduction.  
Although it is difficult to determine whether the reproductive difficulties noted in 
female shiftworkers are related to stressful lifestyle or specifically a disruption of 
circadian rhythmicity, there is evidence from rodent studies to suggest that disruption of 
circadian rhythmicity can lead to aberrant reproductive phenotypes. In female rats, 
ablation of the SCN leads to irregular estrus cyclicity (10) and an inhibition of the LH 
surge (11) and ovulation (12). In addition, the phenotypes of genetically altered mice 
with clock gene deficiencies indicate a role for these rhythm generating genes in 
supporting normal female reproductive phenotype. The most thoroughly characterized 
clock gene deficient mouse is the Clock∆19 mutant. Decreased fertility of Clock∆19 mutant 
females is noted by several groups (9, 13, 14), but refuted in one known report (6). 
Clock∆19 mutant females reportedly experience irregular estrus cycles (6, 9, 15), and no 
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coordinated LH surge on the day of proestrus (15). In addition, these females have low 
progesterone levels at midgestation and a high incidence of midgestational fetal 
resorptions and extended but non-productive labor (15). 
The Clock∆19 mutants studied for reproductive phenotype have a deletion in 
Clock’s transcriptional activation domain which results in dominant-negative, 
antimorphic activity (16-18). These Clock∆19 mutants have a breakdown of wheel-running 
rhythmicity in constant darkness (19). However in light:dark cycles, Clock∆19 mutants are 
reported to exhibit nearly normal wheel-running, with running concentrated in the dark 
period (19, 20). In addition, Clock∆19 mutants selectively bred for a capacity to synthesize 
melatonin produce the hormone rhythmically in both light:dark and dark:dark cycles (20, 
21).  This suggests that central rhythmicity is maintained in these mutants and may 
facilitate their estrus cycle progression and ovulation. 
The more recently generated Clock-/- mice maintain circadian rhythmicity in 
constant darkness (22). This indicates that despite the previously held view in the 
circadian field, Clock is not required for the generation of circadian rhythmicity (22). 
Bmal1-/- mice have a much more robust circadian phenotype than Clock-/- mice. In 
light:dark cycles, Bmal1-/- mice spend more time running in the light phase than do 
Bmal1+/+ mice and are less likely to begin running within 0.5 hours of lights off than 
Bmal1+/+ mice (23). Bmal1-/- mice also experience a complete loss of circadian 
rhythmicity in constant darkness (24). Therefore, Bmal1-/- mice may be valuable in 
examining roles for genes of the molecular clock in addition to generation of circadian 
rhythmicity. Through use of Bmal1-/- mice, effects of Bmal1 on processes seemingly 
unrelated to circadian rhythmicity such as hair growth (25) and ossification of ligaments 
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and tendons (23) have been demonstrated. Infertility of both male and female Bmal1-/- 
mice has been reported (26). Bmal1-/- males have been demonstrated to be deficient in the 
production of testosterone, suggesting a role for Bmal1 in normal steroidogenesis (26). It 
has been suggested that Bmal1-/- females have delayed puberty, irregular estrus cycles, 
and smaller ovaries and uteri, but are able to ovulate (27, 28). However, there has been no 
thorough examination of the reproductive phenotype of these females.  
  In the present report, we characterize reproductive function in female Bmal1-/- 
mice. We find these mice to be infertile, with normal ovulation, but a defect in 
steroidogenesis that results in implantation failure. Our data indicate that Bmal1-/- females 
are unable to generate the high levels of progesterone necessary for successfully 
maintaining gestation. 
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Materials and Methods 
Animals 
Bmal1-/- outbred mice were provided by C. Bradfield (University of Wisconsin) and 
maintained by heterozygote F1 x F1 crosses (24). Genotyping was performed by PCR as 
described (24). Wild-type and heterozygous littermates were used as controls unless 
otherwise noted. Continuous matings of Bmal1+/+ females and Bmal1+/- females were 
analyzed. Average litter size of mated Bmal1+/+ females was 7.33+0.33 pups while 
average litter size of mated Bmal1+/- females was 8.0+1.0 (P=0.4770; n=6, Bmal1+/+ 
litters; n=4, Bmal1+/- litters). Time between litters was 34.20+6.34 days for continuously 
mated Bmal1+/+ females and 39.25+4.64 days for continuously mated Bmal1+/- females 
(P=0.5607; n=8, Bmal1+/+ litters; n=7, Bmal1+/- litters). These interpregnancy intervals 
and litter sizes are similar to those reported by other investigators for control animals 
(29). Animals were maintained on a 12h:12h light:dark cycle. Females were checked for 
presence of a copulatory plug the morning after mating. Morning of the plug (10 am, ZT 
4) was noted as day 0.5 of gestation. All animal experimentation described was 
conducted in accordance with accepted standards of humane animal care and was 
approved by the Washington University in St. Louis animal studies committee.  
Estrus 
Estrus cycle stage was determined in females aged 2 to 6 months by histological analysis 
of vaginal smears for 22 consecutive days. Vaginal smears were taken daily and cell 
morphology was analyzed to determine cycle stage (30). Cycle length was defined as 
time between onsets of estrus. Statistical analysis was by t-test for cycle length and two-
way ANOVA for proportion of time in each estrus stage.  
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Histological Analysis 
Ovaries were collected from virgin females 14 weeks of age. Implantation sites were 
collected from gravid d10.5 females (ZT 4). Tissues were fixed in 4% paraformaldehyde 
overnight, processed, and embedded in paraffin using standard protocols. 6-8 µm sections 
were cut. For ovaries, every 10th section was kept. For implantation sites, every 5th 
section was kept. Sections were stained with hematoxylin and eosin and examined with a 
light microscope.  
Follicle Development 
Ovarian follicle classification was based on the scheme of Pederson and Peters (31). As 
previously described, follicles were counted on five of the largest hematoxylin and eosin-
stained sections from each ovary and standardized to total area of the section (32). Counts 
and area were determined using AxioVision software.  Statistical analysis was by two-
way ANOVA. 
Oocyte and Embryo Recovery 
Females were mated to wild-type males. At ZT 4 on d3.5 of gestation, females were 
sacrificed by cervical dislocation and oocytes and embryos were harvested (33). Briefly, 
the reproductive tract was dissected out and oocytes and embryos were flushed out of the 
fallopian tubes and uterus with PBS. Morphology of oocytes and embryos recovered was 
examined under a microscope. The examiner was blinded to genotype of the mouse. 
Statistical analysis was by t-test for number of oocytes and embryos recovered. 
Hormone Measurements 
Mice were anesthetized with 2.5% avertin and blood was collected by retro-orbital sinus 
sampling using heparinized capillary tubes. Serum was separated by centrifugation and 
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stored at -80°C until assayed. Estradiol and progesterone levels were assayed using solid-
phase 125I-radioimmunoassays according to manufacturer’s protocol (Diagnostic Products 
Corp., Los Angeles, CA). Statistical analysis was by t-test for comparisons at a single 
timepoint and two-way ANOVA for comparisons at multiple timepoints.  
In Situ Hybridization 
In situ hybridization was performed as previously described (34). Briefly, ovaries were 
fixed in 4% paraformaldehyde overnight, followed by three days in 10% sucrose for 
cryopreservation. Ovaries were then embedded in OCT and 14 µm sections were cut on a 
cryostat. Bmal1 and StAR riboprobes were generated from Gen Bank NM_007489 
nucleotides 2324-2637 and Gen Bank NM_011485 nucleotides 541-703 respectively. 
Sense and antisense [α-33P]-labeled cRNA probes were generated from these templates 
using appropriate polymerases and hybridized to slides. After washing, slides were 
exposed to autoradiographic film and scanned at high resolution. Densitometric analysis 
was performed using National Institutes of Health Image software. Statistical analysis 
was by two-way ANOVA. To assess ovarian histology, hybridized slides were stained 
with hematoxylin and eosin and examined with a light microscope.  
Hormone Supplementation 
Females were mated to wild-type males. Starting on d3.5 of gestation, females were 
injected s.c. with 2 mg progesterone (Sigma) in sesame oil daily or 200 µL of sesame oil 
as a vehicle control at ZT 4 as described (35). Serum progesterone levels in hormone 
supplemented mice were confirmed to be at or above levels observed in wild-type gravid 
mice by radioimmunoassay (data not shown). At ZT 4 on d10.5, females were sacrificed 
by cervical dislocation and their uteri examined for the presence of implantation sites. 
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Diameter of whole implantation sites was measured under a light microscope. Frequency 
of implantation was analyzed by Marascuillo procedure. Diameter length and number of 
implantation sites were analyzed by one-way ANOVA.  
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Results 
Bmal1-/- Females Are Infertile With Prolonged Estrus Cycles 
To establish that Bmal1-/- females are infertile, we mated Bmal1-/- females to Bmal1+/+ 
males. No litters ever resulted from these matings although plugs were detected a total of 
eleven times amongst five mated Bmal1-/- females. This is in agreement with previous 
reports indicating that Bmal1-/- females are infertile (26).  To establish whether or not 
these females progress through the estrus cycle, stage of estrus of sexually mature 
females was tracked for 22 consecutive days by histological analysis of vaginal smears. 5 
out of 5 analyzed Bmal1+/+ mice and 5 out of 6 Bmal1-/- females were found to be 
cycling. Although the majority of Bmal1-/- females were found to be cycling, the length of 
the cycle was 49% longer in Bmal1-/- females compared to Bmal1+/+ females (P<0.0001, 
n=5 for each genotype) (Fig. 1, A-C). However, there was no difference in the proportion 
of time spent in any estrus cycle stage between Bmal1-/- and Bmal1+/+ females (Fig. 1D).  
Histological Analysis of Ovaries from 14-Week-Old Females 
Ovaries from 14-week-old females were examined to determine if normal follicular 
development occurs in the infertile Bmal1-/- females. In the ovaries of both Bmal1+/+ and 
Bmal1-/- females, normal, healthy follicles in all stages of development and corpora lutea, 
were observed (Fig. 2A). There were no differences in the abundance of follicles in any 
stage of development in Bmal1-/- versus Bmal1+/+ ovaries (n=4, Bmal1+/+; n=3, Bmal1-/-) 
(Fig. 2B).  
Normal Preimplantation Embryos Present in Bmal1-/- Females 
In order to determine whether Bmal1-/- females ovulate, and, if so, whether oocytes of 
Bmal1-/- females can be fertilized and undergo normal preimplantation development, 
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oocytes and embryos were flushed from the reproductive tract of Bmal1+/+ and Bmal1-/- 
females successfully mated to Bmal1+/+ males at ZT 4 on d3.5 of gestation and examined. 
Oocytes or embryos were present in the reproductive tract of 12 of 15 Bmal1+/+ females 
and 11 of 15 Bmal1-/- females analyzed. Slightly fewer oocytes or embryos were isolated 
from each of the Bmal1-/- females than from Bmal1+/+ females examined, but this was not 
statistically significant (P=0.062; n=12, Bmal1+/+; n=11, Bmal1-/-) (Fig. 3A). In the case 
of both Bmal1-/- and Bmal1+/+ females, the majority of embryos isolated were fertilized 
and healthy (Fig. 3B). Furthermore, in each group, the embryos isolated were 
predominantly in the morula or blastocyst stage as would be expected at this time of 
gestation (Fig. 3C). 
Decreased Serum Progesterone, but Not Estradiol in d3.5 Bmal1-/- Females 
Appropriate regulation of progesterone and estradiol levels is important for the process of 
implantation on d3.5 of gestation in mice (36). Progesterone levels are increased at the 
time of implantation and remain elevated throughout gestation, while a spike in estrogen 
levels occurs on the day of implantation. To determine if the normal hormonal milieu is 
present in Bmal1-/- females to support implantation, serum progesterone and estradiol 
levels were assayed at ZT 4 on d3.5 of gestation. Serum progesterone levels were 
approximately 6.5 fold higher in Bmal1+/+ females than Bmal1-/- females at ZT 4 
(P<0.0001; n=14, Bmal1+/+; n=15, Bmal1-/-) (Fig. 3D). Progesterone levels in Bmal1+/+ 
and Bmal1-/- females were assessed over the circadian day to determine whether 
upregulation of progesterone is merely delayed in the Bmal1-/-females. Serum was 
collected from animals sacrificed at 6 hour intervals beginning 6 hours prior to the d3.5 
ZT 4 timepoint at ZT 22 on d3 of gestation. Progesterone levels were not affected by time 
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of day. Higher progesterone levels in Bmal1+/+ females versus Bmal1-/- females persisted 
at all timepoints (P<0.0001; n=3-4 Bmal1+/+ or Bmal1-/- females per timepoint) (Fig. 3E). 
There was no difference in serum estradiol levels of Bmal1+/+ and Bmal1-/- females at ZT 
4 on d3.5 of gestation (n=12, Bmal1+/+; n=15, Bmal1-/-) (Fig. 3F). 
StAR Expression is Decreased in d3.5 Corpora Lutea of Bmal1-/- Females 
In mice, the corpus luteum is responsible for production of steroid hormones throughout 
gestation. Because serum progesterone levels are significantly lower in d3.5 Bmal1-/- 
females compared to Bmal1+/+ females, Bmal1-/- females were analyzed for potential 
luteal defects. Bmal1 mRNA expression was detected in the corpora lutea of ovaries from 
Bmal1+/+ females at ZT 4 on d3.5 (Fig. 4, A&B). Because Bmal1 transcript expression 
does not change in rat corpora lutea over the circadian day (8), expression was not 
analyzed over the course of 24 hours. Expression of steroidogenic acute regulatory 
protein (StAR), the enzyme responsible for catalyzing the rate-limiting step of 
steroidogenesis, was assessed in d3.5 corpora lutea of Bmal1-/- and Bmal1+/+ females. 
StAR mRNA was robustly expressed in the corpora lutea of Bmal1+/+ females but nearly 
undetectable in the corpora lutea of Bmal1-/- females (Fig. 4, C-F). StAR expression was 
significantly higher in corpora lutea of Bmal1+/+ versus Bmal1-/- females throughout d3.5 
at all timepoints analyzed (P<0.0001, n=3-7 Bmal1+/+ or Bmal1-/- females per timepoint) 
(Fig. 4G). There were no differences in StAR expression in Bmal1+/+ or Bmal1-/- females 
with respect to time of day. Bmal1 and StAR sense in situs are shown in Supplementary 
Figure 1. 
Progesterone Administration Restores Implantation in Bmal1-/- Females 
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In mice, d3.5 is the start of the period of uterine receptivity to implantation (36). At this 
time, serum progesterone levels were found to be significantly lower in Bmal1-/- females 
compared to Bmal1+/+ females (Fig. 3D&E). Therefore, implantation was evaluated. At 
d10.5 of gestation, implantation sites were present in uteri of 75% (6/8) of untreated 
Bmal1+/+ females, 50% (6/12) of Bmal1+/+ females receiving daily injections of vehicle 
starting at d3.5, and 83% (5/6) of Bmal1+/+ females receiving daily injections of 
progesterone starting at d3.5 (Table 1). Implantation sites were never found in untreated 
Bmal1-/- females (0/6) or vehicle treated Bmal1-/- females (0/6) on d10.5 of gestation 
(P<0.05 compared to untreated Bmal1+/+ females). However, when Bmal1-/- females 
received daily injections of progesterone starting at d3.5, 38% (5/13) displayed 
implantation sites at d10.5.  Significantly fewer implantation sites were observed in 
individual gravid Bmal1-/- progesterone treated females versus untreated Bmal1+/+  
females (P<0.05, n=6 Bmal1+/+  females, n=5 Bmal1-/- females). While implantation sites 
in progesterone treated Bmal1-/- females had a smaller diameter than those in each 
Bmal1+/+ female group (P<0.001, n=3 implantation sites from each of 3-4 females per 
group) (Fig 5E), they were histologically normal (Fig. 5A-D).  
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Discussion  
Although Bmal1-/- females have previously been noted to be infertile (26), this report 
marks the first systematic characterization of their reproductive phenotype. Because 
clock genes have a described role in regulating GnRH pulsatility (9), and circadian 
regulation of the LH surge has been demonstrated (37), impaired ovulation seemed a 
likely cause of this infertility. However, failed ovulation is not observed in these females. 
Intact ovulation is suggested by the presence of corpora lutea in virgin Bmal1-/- females 
(Fig. 2) and confirmed by the presence of oocytes and embryos in the reproductive tract 
of Bmal1-/- females at d3.5 of gestation (Fig. 3A). While ovulation occurs in the Bmal1-/- 
females, steroid hormone deficiency appears to hinder later stages of reproduction. Under 
normal conditions, progesterone levels are robustly increased at d3.5, the time of 
implantation, and remain high throughout gestation. Progesterone-responsive genes such 
as Hoxa10 and Hoxa11 (38) have roles in uterine receptivity, implantation, and 
decidualization (36). After implantation, high levels of progesterone are responsible for 
maintaining uterine quiescence. Progesterone deficiency is observed in Bmal1-/- dams at 
the time of implantation (Fig. 3D&E), and this deficiency persists at midgestation (data 
not shown). Regulation of estradiol levels is also important for coordinating implantation. 
However, there is no difference in estradiol levels in Bmal1-/- females compared to 
Bmal1+/+ females (Fig. 3F). Similarly, a significant decrease in levels of progesterone but 
not estradiol has been reported for StAR-/- females (39). During gestation, estradiol is 
present at considerably lower levels than progesterone. Therefore, a defect in 
steroidogenesis may have a greater effect on progesterone levels than estradiol levels.  
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In mice, the corpora lutea are responsible for steroid hormone production 
throughout gestation. Interestingly, corpora lutea of pregnancy were observed 
significantly less frequently in d3.5 Bmal1+/+ females (12/12) versus d3.5 Bmal1-/- 
females (6/16) (P<0.0005), indicating a luteinization defect in the Bmal1-/- females. 
Expression of Bmal1 mRNA in the corpora lutea of d3.5 Bmal1+/+ females (Fig. 4, A&B) 
indicates a potential role for Bmal1 in this organ. On d3.5, the corpora lutea of Bmal1-/- 
females fail to express StAR, an enzyme required for steroidogenesis, to the levels 
observed in Bmal1+/+ females (Fig. 4, C-G). A similar defect exists in the Bmal1-/- male. 
Alvarez et al. reported that Bmal1-/- males have decreased levels of testosterone and a 
corresponding decreased expression of StAR mRNA in the testis (26). This group also 
demonstrated the ability of BMAL1 to increase StAR expression in the MA-10 Leydig 
cell line (26). The CLOCK/BMAL1 heterodimer has also been shown to increase StAR 
expression in cultured chicken granulosa cells (40). As Bmal1 mRNA is expressed in 
d3.5 corpora lutea of Bmal1+/+ females, BMAL1 may be a direct regulator of StAR 
expression in the corpora lutea of Bmal1+/+ females. Interestingly, because levels of 
serum progesterone and StAR expression do not change with respect to time of day, the 
observed steroidogenesis defect appears to result from a clock-independent role of 
Bmal1. 
Implantation was never observed in either untreated or vehicle treated mated 
Bmal1-/- females. However, progesterone supplementation starting on d3.5 was able to 
reinstitute implantation in these females (Table 1). The observation of histologically 
normal implantation sites in these progesterone supplemented Bmal1-/- females (Fig. 5D) 
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indicates that insufficient progesterone is a major factor in the observed implantation 
defect.  
In addition to indicating that impaired steroidogenesis accounts for implantation 
failure in Bmal1-/- mice, this study reveals the existence of multiple reproductive defects 
in Bmal1-/- females. Bmal1-/- females had a lower number of oocytes and embryos present 
in the reproductive tract at d3.5 (Fig. 3A) and a lower number of implantation sites 
present in the uterus at d10.5  after progesterone treatment (Table 1) than Bmal1+/+ 
females, suggesting potential irregularity of the hormonal milieu necessary for 
precipitating ovulation. In addition, the smaller size of the implantation sites in 
progesterone supplemented Bmal1-/- females suggests that Bmal1-/- females may have 
uterine abnormalities preventing normal maintenance of gestation. Further exploration of 
the many roles of Bmal1 in female reproduction is warranted. The data presented here 
indicate an important role for Bmal1 in steroidogenesis in the gonad and suggest that 
Bmal1 may have a similar function in other heretofore unanalyzed     steroidogenic 
tissues. 
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Figure 1. Prolonged estrus cycles in Bmal1-/- females. Estrus cycle was assessed by 
histological analysis of vaginal smears. Progression through the stages of the estrus 
cycle in representative Bmal1+/+ (A) and Bmal1-/- (B) females. Mean cycle length 
(C) and proportion of time spent in each estrus stage (D). n=5 for each group. Values 
are means +/-SEM. *p<0.001.
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Figure 2. Normal follicular development in Bmal1-/- females. Follicles were counted 
on sections of hematoxylin and eosin stained ovary. A, Normal preantral follicles 
(indicated by arrows), antral follicles (indicated by arrows), and corpora lutea in Bmal1+/+ 
and Bmal1-/- ovaries. Black bars=50μm. B, Abundance of follicles in different stages of 
development. Values are means +/- SEM. n=4, Bmal1+/+; n=3, Bmal1-/-. PF, primoridial 
and primary follicles; PrF, preantral follicles; APrF, atretic preantral follicles; AnF, antral 
follicles; AAnF, atretic antral follicles; CL, corpora lutea.
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Figure 3. Healthy preimplantation embryos, but low serum progesterone levels in 
Bmal1-/- females at d3.5 of gestation. Oocytes and embryos were flushed from the 
reproductive tract at d3.5 of gestation and analyzed under a light microscope. Serum 
progesterone and estradiol at d3.5 of gestation were assayed by solid-phase 125I-RIA. 
A, Average number of oocytes/embryos isolated from each gravid female. Values are 
means +/- SEM. Numbers in bars indicate the number of females with oocytes or 
embryos/the total number of females analyzed. B, Percentage of embryos isolated 
identified as healthy, unfertilized, and degenerating. C, Percentage of healthy embryos 
isolated in the blastocyst or morula stage. D, Serum progesterone at ZT 4 on d3.5. n=14, 
Bmal1+/+; n=15, Bmal1-/-. Values are means +/- SEM. *p<0.0001. E, Circadian serum 
progesterone throughout d3.5. n=3, Bmal1+/+; n=3-4, Bmal1-/- per timepoint. Values are 
means +/- SEM. p<0.0001 with respect to genotype.  F, Serum estradiol. n=12, Bmal1+/+; 
n=15, Bmal1-/-. Values are means +/- SEM.
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Figure 4. Bmal1 and StAR are expressed in corpora lutea of d3.5 Bmal1+/+ females. 
Ovary sections were subjected to in situ hybridization with radiolabeled antisense Bmal1 
or StAR probes and then hematoxylin and eosin stained for histological analysis. 
A, Autoradiograph from in situ hybridization for Bmal1 at ZT 4 d3.5. B, Hematoxylin 
and eosin staining of the same section. Arrows point to corpora lutea. Black bar=200μm. 
C and E, Representative autoradiographs from in situ hybridization for StAR at ZT 4 d3.5. 
D and F, Hematoxylin and eosin staining of the same sections. Arrows point to corpora 
lutea. Black bars=200μm. n=3, Bmal1+/+; n=3, Bmal1-/-. G, Circadian StAR expression 
throughout d3.5. Values are means +/- SEM. n=3, Bmal1+/+; n=3-7, Bmal1-/- per timepoint. 
+ denotes no corpora lutea observed in any mice examined at this timepoint. p<0.0001 
with respect to genotype. 
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Figure 5. Implantation sites found in progesterone supplemented Bmal1-/- females 
are small, but histologically normal. Paraffin sections of implantation sites were 
hematoxylin and eosin stained. Diameter of whole implantation sites was measured 
under a light microscope. Representative implantation sites from untreated Bmal1+/+ 
females (A), vehicle treated Bmal1+/+ females  (B), progesterone treated Bmal1+/+ 
females (C), and progesterone treated Bmal1-/- females (D). Black bar=1 mm. Em, 
embryo; Pl, placenta; FM, fetal membranes; Ut, uterus. E, Implantation site diameter. 
n=3 implantation sites from each of 3-4 females per group. * denotes p<0.001 compared 
to each of the other groups.
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Supplementary Figure 1. Bmal1 and StAR sense in situs. Sequential ovary sections 
were subjected to in situ hybridization with radiolabeled sense Bmal1 or StAR probes 
and then hematoxylin and eosin stained for histological analysis. Autoradiographs from 
in situ hybridization for Bmal1 (A) and StAR (B) at ZT 4 d3.5, and hematoxylin and 
eosin staining of an adjacent section (C). 
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Table 1. 
Maternal 
Genotype
Ave. No. 
of IS
% with 
d10.5 IS
75%
(6/8)
0%
(0/6)
N/A
Females were mated to wild-type males. 
Vehicle and P4 treated females were 
injected s.c. daily starting at d3.5 of 
gestation. * denotes P<0.05 compared to % 
with IS for Bmal      (untreated). + denotes 
P<0.05 compared to ave. no. IS for Bmal1
(untreated). P4 dose was 2 mg per day. IS, 
implantation site; P4, progesterone.
Implantations in d10.5 females
50%
(6/12)
0%
(0/6)
38%
(5/13)
N/A
7.5
5.6 +
8.5
83%
(5/6) 8
(untreated)
(untreated)
*
*
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Abstract 
 
Evidence in humans and rodents suggests the importance of circadian rhythmicity in 
parturition. A molecular clock underlies the generation of circadian rhythmicity. While 
this molecular clock has been identified in numerous tissues, the expression and regulation 
of clock genes in tissues relevant to parturition is largely undefined. Here, we examine the 
expression and regulation of the clock genes Bmal1, Clock, Cry(Cryptochrome)1/2, and 
Per(Period)1/2 in the murine gravid uterus, placenta, and fetal membranes during late 
gestation. All clock genes examined were expressed in the tissues of interest throughout 
the last third of gestation. Upregulation of a subset of these clock genes was observed in 
each of these tissues in the final two days of gestation. Oscillating expression of mRNA 
for a subset of the examined clock genes was detected in the gravid uterus, placenta, and 
fetal membranes. Furthermore, bioluminescence recording on explants from gravid 
Per2::luciferase mice indicated rhythmic expression of PER2 protein in these tissues. 
These data demonstrate expression and rhythmicity of clock genes in tissues relevant to 
parturition indicating a potential contribution of peripheral molecular clocks to this 
process. 
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Introduction 
 
Successful parturition is necessary for survival of the species. Mammalian species exhibit 
a tendency to begin labor and deliver at a characteristic time of day. Moreover, the study 
of female shiftworkers indicates that disruption of circadian rhythmicity may lead to 
preterm labor and low birth weight (1). These observations suggest that parturition may 
be a circadian controlled process. 
 Circadian rhythmicity is generated by the oscillating expression levels of clock genes 
(2). Transcriptional feedback loops help drive these oscillations. The CLOCK:BMAL1 
heterodimer drives transcription of a group of genes including the  Period(Per) and 
Cryptochrome(Cry) genes by binding to E-box enhancers. PER and CRY complex and 
inhibit the ability of the CLOCK:BMAL1 heterodimer to act as an enhancer, thus 
shutting down their own transcription (2). Post-translational modification, notably 
phosphorylation, of clock proteins also plays a role in driving the molecular clock (2).  
 The clock genes are expressed not only in the suprachiasmatic nucleus (SCN), 
which is regarded as the masterclock of the organism, but also in numerous other 
peripheral tissues. Clock genes in the retina (3) and skeletal muscle  (4) have been shown 
to have roles independent of clock genes expressed in the SCN. Rhythmic expression of 
clock genes has been noted in female reproductive tissues including the ovary (5), oviduct 
(6), and uterus (7) of non-gravid rodents (reviewed in (8)). Little information exists on the 
presence of the molecular clock in tissues involved in the resolution of pregnancy such as 
the gravid uterus and specific tissues of the conceptus. 
 Previous studies on rhythmic clock gene expression in the conceptus have focused on 
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the fetal SCN. The mouse fetal SCN develops between days 12 and 15 of gestation (9), and 
exhibits circadian oscillation of Per1 transcript by day 17 of gestation (10). One study 
using in vivo bioluminescent imaging of pregnant Per1::luciferase rats indicated expression 
of Per1 in the fetus by day 10 of gestation and diurnal fluctuation in the expression of Per1 
by day 12 (11). However, in this study it was not possible to determine the fetal tissues that 
contributed to the gene expression observed.  
 Rodent studies indicate a role for clock genes in the resolution of pregnancy. An 
impact of maternal SCN-lesioning on the timing of labor in rats has been demonstrated. 
For normal rats, the onset of labor occurs with two peaks of frequency 24 hours apart on 
days 21 and 22 of gestation. SCN-lesioned rats, however, labor during this same time 
period with a single peak in frequency midway between the two normal peak times (12). 
This indicates a role in parturition initiation for the central molecular clock located in the 
SCN. ClockΔ19 mutant mice, which have a deletion in the transcriptional activation domain 
of Clock resulting in dominant-negative function in all tissues, display high incidences of 
midgestational fetal resorption and extended but nonproductive labor (13).  These studies 
suggest a potential role for genes of the molecular clock in regulating the onset and 
progression of parturition. 
 The presence of peripheral molecular clocks in the gravid uterus and non-SCN 
tissues of the conceptus has not previously been described. In the present report, we 
examine the expression of clock genes in the gravid mouse uterus, placenta, and fetal 
membranes during late gestation. We find that the core clock genes are expressed 
throughout the final third of gestation in these tissues. In many cases, expression of clock 
genes is rhythmic and regulated with respect to progression through gestation. Therefore, 
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peripheral molecular clocks exist in tissues relevant to parturition. 
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Materials and Methods 
Experimental Animals 
Male and female C57BL/6/SvJ/129 mixed, C57BL/6, and knock-in mice (congenic on 
C57Bl/6J) expressing a mPeriod2::luciferase (Per2::Luc) fusion protein (14) were fed ad 
libitum and maintained on a 12 h light/dark cycle. Lights on was designated as ZT 0. 
Females in C57BL/6/SvJ/129 x C57BL/6/SvJ/129, C57BL/6 x C57BL/6, and Per2::luc x 
Per2::luc matings were checked for presence of a copulatory plug the morning after 
mating. Morning of the plug (1000 h, ZT 4) was noted as 0.5 days post-coitum (dpc) and 
the female was removed from the cage with the male. While for late gestational profiling 
and PER2 bioluminescence studies mating was continuous until plug detection, for 
circadian profiling females were mated to males for a limited time window of four hours 
nightly. This was done in order to facilitate detection of small fold change differences in 
transcript over the circadian day in tissues from these females. All animal 
experimentation described was conducted in accordance with accepted standards of 
humane animal care and was approved by the Washington University Animal Studies 
Committee. 
Real-time qPCR 
Uterus, placenta, and fetal membranes (amnion/chorion) were harvested from gravid 
C57BL/6/SvJ129 females for late gestational profiling and C57BL/6 females for 
circadian profiling, snap frozen in liquid nitrogen, and stored at -80°C until processing. 
For late gestational profiling, tissues were collected at ZT 4 (.5 dpc samples) or ZT 12 (.0 
dpc samples) (n=3 animals per timepoint). For circadian day profiling, samples were 
collected at specified ZTs (n=3 animals per timepoint). Total RNA was extracted from 
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tissue samples using TriZol reagent (Invitrogen). RNA from individual samples was 
converted to cDNA using Quantitect Reverse Transcription Kit (Qiagen), which includes 
a step for elimination of genomic DNA. Previously reported forward and reverse primers 
for Bmal1, Clock, Cry1, Cry2, Per2 (15), Per1 (16), Dbp (17), and Actg(Actin) (18) were 
used. The amplification efficiency of these primers was verified as described by the 
system manufacturer (Applied Biosystems, Foster City, CA). Forward and reverse 
Gapdh(glyceraldehyde 3-phosphate dehydrogenase) primers were designed using Primer 
Express software. These primers were validated for use with real-time qPCR by 
determining amplification efficiency and optimal primer conditions as described by the 
system manufacturer (Applied Biosystems, Foster City, CA). Gapdh was used for 
standardization in all experiments except for the late gestational profiling of clock gene 
expression in the fetal membranes because this gene was upregulated in this tissue on the 
final days of gestation. In these studies, Actg primers were used for standardization. All 
primer sequences are reported in Table 1. Reactions were completed on the Applied 
Biosystems 7500 Fast Real-Time PCR System. PCR conditions were as follows: one cycle 
at 50°C for 2 minutes, one cycle at 95°C for 10 minutes, and 40 cycles of 95°C for 15 
seconds and 60°C for one minute. A subsequent step to generate a dissociation curve was 
used to verify that a single amplicon was generated. Reactions were prepared using Power 
SYBR Green PCR Master Mix (Applied Biosystems) and 500 nM each of forward and 
reverse Dbp primers, 900 nM each of forward and reverse Gapdh primers, or forward and 
reverse primers for other genes at concentrations previously described (15, 16, 18). 
Sequence Detection Software (v1.3.1) was used to determine the Ct value for each reaction. 
The ΔΔCt method was used for quantification (19). Statistical analysis was by one-way 
ANOVA, followed by Bonferroni’s post hoc test. Comparisons were considered 
statistically significant when p values were <0.05. 
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Tissue Explant Culture and Bioluminescence Recording 
 
Uterus, placenta, and fetal membranes (amnion/chorion) were harvested from each of 
three gravid Per2::luc females at ZT2-4 on the morning of 16.5 dpc (n=3 mice; 5-6 
fetuses). Tissue explants were cultured in 1 ml of DMEM (Invitrogen) supplemented with 
10 mM HEPES, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.1 mM beetle luciferin 
(Promega, Madison, WI) according to published methods (20). Placenta explants were 
placed on Millicell membranes (Millipore, Bedford, MA). Each explant was sealed in a 35 
mm Petri dish with a coverslip and vacuum grease and maintained at 36°C in darkness. 
Bioluminescence was continuously monitored with a photomultiplier tube (Hamamatsu, 
Shizouka, Japan) for 4-6 days. Data sets were detrended by subtracting the 24-h running 
average from the raw data.  We then added the mean of the raw bioluminescence to each 
trace and plotted this as detrended bioluminescence. 
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Results 
Expression and regulation of clock genes in the final third of gestation 
To determine whether clock genes are expressed and regulated in parturition-relevant tissues 
as gestation progresses, expression of Bmal1, Clock, Cry1/2, and Per1/2 was evaluated in 
uterus, placenta, and fetal membranes from females 14.5 to 19.0 dpc by real-time qPCR 
(n=3 mice per timepoint). Parturition was expected to occur at approximately 19.5 dpc. 
Tissues were harvested at ZT 4 (.5 dpc timepoints) or ZT12 (.0 dpc timepoints). 
 In the uterus, expression of all examined genes was noted by 14.5 dpc and persisted 
through 19.0 dpc (Figure 1A-F). In the uterus, Cry1 was the only gene to undergo 
significant changes over the final third of gestation (p<0.05; one-way ANOVA), with an 
increase at 18.0 dpc (p<0.05 vs. 14.5, 15.5, 16.5, 17.5, 18.5, and 19.0 dpc) (Figure 1C).  
 Expression and significant changes in each of the genes examined was observed over 
the final third of gestation in the placenta (p<0.05; one-way ANOVA) (Figure 2A-F). An 
increase in Bmal1 expression was observed at 18.5 dpc (p<0.05 vs. 14.5, 15.5, 16.0, 16.5, 
17.0, 17.5, and 18.0 dpc) (Figure 2A). Clock expression was increased at 18.5 dpc (p<0.05 
vs. 16.0) and 19.0 dpc (p<0.05 vs. 14.5, 15.5, 16.0, 16.5, and18.0 dpc) (Figure 2B). Cry1 
expression was increased at 18.0 dpc (p<0.05 vs. 14.5 dpc) (Figure 2C). Cry2 expression 
was increased at 19.0 dpc (p<0.05 vs. 14.5, 15.5, 16.0, and 16.5 dpc) (Figure 2D).  Per1 
expression was increased at 18.5 dpc (p<0.05 vs. 14.5 dpc) (Figure 2E). Per2 expression 
was increased at 19.0 dpc (p<0.05 vs. 14.5, 15.5, 16.0, 16.5, and 17.0 dpc) (Figure 2F).     
 Likewise, expression of all examined clock genes was observed in the fetal 
membranes by 14.5 dpc and persisted through 19.0 dpc (Figure 3A-F). Significant changes 
in expression over the final third of gestation were noted only in Bmal1 (p<0.05; one-way 
ANOVA). Bmal1 expression was increased at 17.5 dpc (p<0.05 vs. 14.5, 16.0, and 16.5 
dpc) and 19.0 dpc (p<0.05 vs. 14.5 dpc) (Figure 3A). 
Circadian oscillation of clock gene transcripts during late gestation  
To determine whether clock gene transcript expression is rhythmic in uterus, placenta, and 
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fetal membranes during late gestation, expression of Bmal1, Clock, Cry1/2, and Per1/2 was 
evaluated at 4-hour intervals during day 16 of gestation by real-time qPCR (n=3 mice per 
timepoint).  
 In the uterus, significant circadian changes were noted only in expression of Cry1 
(p<0.05; one-way ANOVA), with changes in Bmal1 approaching significance (p=0.053; 
one-way ANOVA) (Figure 4A-C). In placenta, significant changes in Cry1 and Per1 were 
noted over the course of the day (p<0.05; one-way ANOVA), with changes in Cry2 
approaching significance (p=0.053; one-way ANOVA) (Figure 4D-F). For Cry1, the 
observed maxima at ZT 16 is significantly different from the minima at ZT 0 and ZT 4 
(p<0.05). Likewise, the Per1 maxima at ZT 12 is significantly different from the minima at 
ZT 4 (p<0.05). In the fetal membranes, changes in Bmal1, Cry2, and Per1 were observed 
with respect to time of day (p<0.05; one-way ANOVA) (Figure 4G-I).  
 The transcript expression of the clock-regulated gene Dbp was also examined in the 
uterus, placenta, and fetal membranes during day 16 of gestation. Dbp transcription is 
known to be controlled by binding of the CLOCK:BMAL1 heterodimer to E-box enhancers 
in the gene (21); therefore oscillations in Dbp support that the molecular clock is 
functioning. Significant differences (p<0.05; one-way ANOVA) in Dbp expression over the 
circadian day were observed in uterus and placenta (Figure 5A&B). In uterus, the maxima at 
ZT 12 is significantly different from the minima at ZT 0 (p<0.001). In placenta, the maxima 
at ZT 12 is significantly different from the minima at ZT 20 (p<0.05). Changes observed 
over the circadian day in the fetal membranes were not significant (Figure 5C).  
Circadian oscillation of PER2 protein during late gestation 
The circadian oscillations of clock gene mRNA detected in late gestation may or may not 
translate to oscillation in protein. To examine potential circadian oscillations in PER2, tissue 
explants from three homozygous Per2::luc dams at 16.5 dpc were subjected to    
bioluminescence recording.  Uterus, placenta, and fetal membranes all showed damped 
circadian bioluminescence indicating rhythmic expression of PER2 protein (Figure 6).  
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Using the daily peak bioluminescence as a phase marker, we found the periods of uterine 
(21.4 +/- 5.2 h, n=4 explants), fetal membranes (21.2 +/- 2.3 h, n=5), and placental  
explants (19.5 +/- 1.8 h, n=4) did not differ (p>0.05, One-way ANOVA).  These tissues 
reached their first peak of bioluminescence between 0.7 and 3.5 h after explantation, around 
the time of projected dusk. 
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Discussion  
Given the known circadian gating to the timing of birth and disturbances to the progression 
of labor in ClockΔ19 females (13), we hypothesized that peripheral molecular clocks exist in 
tissues relevant to parturition. This report indicates that clock genes are expressed in the 
murine gravid uterus, placenta, and fetal membranes. In many cases clock gene expression 
is rhythmic and regulated with respect to progression through gestation.   
 Here we report, for the first time, evidence that the gravid uterus, placenta, and fetal 
membranes express genes of the molecular clock. Rhythmic expression of transcript for 
some, but not all, of the examined clock genes was observed in uterus, placenta, and fetal 
membranes over day 16 of gestation (Figure 4).  While rhythmic expression of transcript 
was in many cases detected, it is possible that either our 4-hour intervals missed a peak in 
expression or our real-time qPCR conditions were not sensitive enough to detect lower 
amplitude rhythms of transcripts that appeared nonrhythmic. Alternatively, there may be a 
reliance on translational or post-translational control to generate rhythmicity of some of 
these genes in these tissues at this time. Rhythmic expression of PER2 in each of the 
examined tissues indicates that rhythmicity exists at the protein level (Figure 6). In uterus 
and placenta, rhythmic expression of transcript for Dbp, a clock-regulated gene, further 
indicates the presence of molecular clock function (Figure 5A&B).  
 In the uterus, circadian regulation of Cry1 transcript was observed (Figure 4B), with 
regulation of Bmal1 in antiphase to Cry1 approaching significance (Figure 4A). This 
pattern of expression is expected since in most tissues examined previously, Bmal1 cycles 
antiphase to negative regulators Cry and Per. Circadian expression of Bmal1, Cry1, and 
Per2 transcript has previously been examined in non-gravid mouse uterus (7). The Cry1 
profile of gravid uterus reported here is similar in magnitude and time of peak and nadir to 
data previously reported for non-gravid uterus (7). However, some discrepancies exist 
between the previously reported non-gravid uterus data and the gravid uterus data presented 
here. The Bmal1 profile for gravid uterus has similar time of peak and nadir but smaller 
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magnitude of change compared to that reported for non-gravid uterus (7). While a circadian 
change in expression of Per2 transcript has been reported for non-gravid uterus (7), we do 
not observe such a change in gravid uterus here. Given the numerous physiological and 
gene expression changes occurring in the uterus during gestation, such differences in 
regulation of clock genes is not unexpected.  
 In the placenta, circadian oscillation of Cry1 and Per1 was observed, with regulation 
of Cry2 approaching significance (Figure 4E&F). The oscillation observed in each of these 
genes in the placenta is in phase with one another as expected. The changes in expression 
observed in the placenta are of a similar magnitude as those observed in the uterus.  
 In the fetal membranes, oscillation in expression of Bmal1, Cry2, and Per2 were 
observed with respect to time of day (Figure 4G-I). These changes are similar in magnitude 
to gene expression changes observed in uterus and placenta. The changes in Bmal1 are 
antiphase to those seen in Cry2 and Per2. 
 Bioluminescent imaging of tissue explants from gravid Per2::luc females indicates 
oscillating expression of PER2 protein in gravid uterus, placenta, and fetal membranes 
(Figure 6). Significant oscillations in Per2 transcript were detected in the placenta, but not in 
the gravid uterus or fetal membranes. The observed oscillations of PER2 in the uterus and 
fetal membranes may therefore be a result of regulation at the translational or post-
translational level. Oscillating clock protein levels in the presence of nonrhythmic transcript 
expression has been demonstrated previously (22).  
 Regulation of clock genes as parturition approaches may support a role for these 
genes in the initiation of labor. Upregulation in transcript for some or all of the examined 
clock genes was observed over the final two days of gestation in the current study. In the 
uterus, Cry1 expression increases at day 18.0 (Figure 1).  In the placenta, expression of 
each of the examined clock genes is observed between days 18.0 and 19.0 (Figure 2). In the 
fetal membranes, Bmal1 expression increases significantly at days 17.5 and 19.0 (Figure 3).   
The timing of these inductions is consistent with a possible role for these genes in 
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regulating the cascade of events controlling the initiation of parturition. These genes could 
be impacting parturition through either conventional clock effects or a previously 
undetermined nonconventional effect. Because clock gene conventional knockout and 
mutant mice are subfertile or infertile (23-27), conditional clock gene knockout mice will be 
important in ascertaining the role of clock genes in parturition. 
 Roles of molecular clock genes specific to peripheral tissues have been 
demonstrated (3, 4). We report here that molecular clocks exist in tissues important to 
parturition. Clock genes thus have the potential to impact parturition.  Dissecting the 
roles of clock genes in peripheral tissues may lead to new insights into this critical but 
poorly understood process.  
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Figure 1. Clock gene expression in uterus during late gestation. Pregnant female 
mice were sacrificed at 9 timepoints during the final third of gestation starting with 
14.5 dpc and ending on 19.0 dpc.  Tissues were collected from three females per 
timepoint and analyzed for mRNA expression by real-time qPCR. Expression is 
normalized to Gapdh. Expression of A) Bmal1, B) Clock, C) Cry1 (p<0.05; one-way 
ANOVA), D) Cry2, E) Per1, and F) Per2 mRNA. Values are means +/- SEM. *denotes 
timepoints significantly different from others by Bonferroni's post hoc test, p<0.05.
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Figure 2. Clock gene expression in placenta during late gestation. Pregnant female 
mice were sacrificed at 9 timepoints during the final third of gestation starting with 
14.5 dpc and ending on 19.0 dpc.  Tissues were collected from three females per 
timepoint and analyzed for mRNA expression by real-time qPCR. Expression is 
normalized to Gapdh. Expression of A) Bmal1, B) Clock, C) Cry1 (p<0.05; one-way 
ANOVA), D) Cry2, E) Per1, and F) Per2 mRNA. Values are means +/- SEM. *denotes 
timepoints significantly different from others by Bonferroni's post hoc test, p<0.05.
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Figure 3. Clock gene expression in fetal membranes during late gestation. Pregnant 
female mice were sacrificed at 9 timepoints during the final third of gestation starting 
with 14.5 dpc and ending on 19.0 dpc.  Tissues were collected from three females per 
timepoint and analyzed for mRNA expression by real-time qPCR. Expression is 
normalized to Actg. Expression of A) Bmal1, B) Clock, C) Cry1 (p<0.05; one-way 
ANOVA), D) Cry2, E) Per1, and F) Per2 mRNA. Values are means +/- SEM. *denotes 
timepoints significantly different from others by Bonferroni's post hoc test, p<0.05.
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Figure 4. Clock gene expression in gravid uterus, placenta, and fetal membranes from 
16.0-17.0 dpc. Pregnant female mice were sacrificed at 4-hour intervals during day 16 
of gestation at ZT0, ZT4, ZT8, ZT12, Z16, and ZT20. Tissues were collected from three 
females per timepoint and analyzed for mRNA expression by real-time qPCR. Expression 
is normalized to Gapdh. Expression of A) Bmal1  (p=0.053; one-way ANOVA) and Clock, 
B) Cry1 (p<0.05; one-way ANOVA) and Cry2, and C) Per1 and Per2 in uterus. Expres-
sion of D) Bmal1 and Clock, E) Cry1 (p<0.05; one-way ANOVA) and Cry2  (p=0.053; 
one-way ANOVA), and F) Per1 (p<0.05; one-way ANOVA) and Per2 in placenta. 
Expression of G) Bmal1 (p<0.05; one-way ANOVA) and Clock, H) Cry1 and Cry2 
(p<0.05; one-way ANOVA), and I) Per1 (p<0.05; one-way ANOVA) and Per2  in fetal 
membranes. Values are means +/- SEM. *denotes peaks significantly different from nadirs 
by Bonferroni's post hoc test, p<0.05.
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Figure 5. Dbp expression in gravid uterus, placenta, and fetal membranes from 
16.0-17.0 dpc. Pregnant female mice were sacrificed at 4-hour intervals during 
day 16 of gestation at ZT0, ZT4,  ZT8, ZT12, Z16, and ZT20. Tissues were 
collected from three females per timepoint and analyzed for mRNA expression 
by real-time qPCR. Expression is normalized to Gapdh. Expression of Dbp in 
A) uterus (p<0.05; one-way ANOVA), B) placenta (p<0.05; one-way ANOVA), 
and C) fetal membranes. Values are means +/- SEM. *denotes peaks significantly 
different from nadirs by Bonferroni's post hoc test, p<0.05.
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Figure 6. PER2 rhythms in gravid uterus, placenta, and fetal membranes. 
Representative Per2::luc bioluminescence recordings from cultured A) uterus, 
B) placenta, and C) fetal membranes. Recordings were taken from tissues 
harvested from each of three pregnant Per2::luc females.
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Gene     GenBank accession no. Primers
Reference
(if applicable)
Bmal1
Clock
Cry1
Cry2
Per1
Per2
Gapdh
Actg
Dbp
NM_007489
NM_007715
NM_007771
NM_009963
NM_011065
NM_011066
NM_008084
F: 5’-CCAAGAAAGTATGGACACAGACAAA-3’
R: 5’-GCATTCTTGATCCTTCCTTGGT-3’
F: 5’-TTGCTCCACGGGAATCCTT-3’
R: 5’-GGAGGGAAAGTGCTCTGTTGTAG-3’
F: 5’-CTGGCGTGGAAGTCATCGT-3’
R: 5’-CTGTCCGCCATTGAGTTCTATG-3’
F: 5’-TGTCCCTTCCTGTGTGGAAGA-3’
R: 5’-GCTCCCAGCTTGGCTTGA-3’
F: 5’-ATGCTCGCCATCCACAAGA-3’
R: 5’-GCGGAATCGAATGGGAGAAT-3’
NM_016974 F: 5’-AGGAACTGAAGCCTCAACCAATC-3’
R: 5’-CTCCGGCTCCAGTACTTCTCAT-3’
Yang et al. 2006
 
Noshiro et al. 2005
Yamamoto et al. 2005F: 5’-GAAAGAAACCTCTGGCTGTTCCT-3’
R: 5’-GCTGACGACGGATCTTTCTTG-3’
F: 5’-ATTGTGGAAGGGCTCATGAC-3’
R: 5’-AGTGGATGCAGGGATGATGT-3’ 
NM_009609 F: 5’-GAAGGAGATCACAGCCCTAGCA-3’
R: 5’-GACAGTGAGGCCAGAATGGAG-3’
Duncan et al. 2006
Yang et al. 2006
 
Yang et al. 2006
 
Yang et al. 2006
 
Yang et al. 2006
 
Table 1. Primers for real-time qPCR
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Abstract 
 
Human and rodent studies indicate a role for circadian rhythmicity and associated clock 
gene expression in supporting normal parturition. The importance of clock gene 
expression in tissues outside the suprachiasmatic nucleus is emerging. Here, we use a 
Bmal1 conditional knockout mouse line with a novel Cre transgenic line to examine the  
role of myometrial Bmal1 in parturition. Females with disrupted myometrial Bmal1 are 
less likely to labor during the dark phase of normal light:dark cycles than their littermate 
controls. Furthermore, these females have altered expression levels of contractile-
associated proteins in the uterus during late gestation. These data indicate a specific role 
for myometrial Bmal1 in supporting normal parturition. 
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Introduction 
 
Although crucial for successful mammalian reproduction, the process of parturition is at 
best incompletely understood. Parturition appears to be a circadian-regulated process. 
Mammalian species exhibit a tendency to begin labor and deliver at a characteristic time of 
day. Epidemiological data from two separate studies indicate that humans tend to labor in 
the early morning hours (1, 2). Mice deliver in the dark phase of a light:dark cycle, while 
rats and hamsters deliver during the light phase. Furthermore, female shiftworkers have 
increased incidences of preterm labor and low birth weight babies (3), suggesting that 
disruption of circadian rhythmicity may result in parturition difficulties. Circadian 
rhythmicity is driven by a group of core clock genes, including Clock, Bmal1, Cry1/2, and 
Per1/2 (4). These genes are expressed in the suprachiasmatic nucleus (SCN) of the 
hypothalamus, which serves as the master clock of the organism, as well as in many 
peripheral tissues. In mice, expression of clock genes has been shown in gravid uterus, fetal 
membranes, and placenta (5), suggesting a role for clock gene expression in these tissues in 
supporting normal parturition. 
Rodent studies further support an importance of circadian rhythmicity and 
associated clock genes for normal parturition. Lesions of the SCN on day 19 of gestation 
in pregnant female rats has been shown to change the circadian gating of parturition. Rats 
normally deliver during a 36-hour time window with two peaks in frequency of 
parturition on days 21 and 22 of gestation. These peaks occur 24 hours apart. However, 
SCN-lesioned rats show one peak in parturition frequency at a time in between those of 
the two normal peaks (6). Abnormal phenotypes have also been noted for ClockΔ19/ 
ClockΔ19 mice during the end stages of reproduction. These females have a high incidence 
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of midgestational fetal resorption (7) and increased rates of prolonged, but nonproductive 
parturition (7, 8).  
ClockΔ19/ ClockΔ19 mice have a deletion in Clock’s transcriptional activation 
domain resulting in antimorphic activity of the protein (9-11). While these mice have a 
breakdown of rhythmicity in constant darkness (12), the more recently generated Clock-/- 
mice maintain rhythmicity in constant darkness (13). Since Bmal1-/- mice lose circadian 
rhythmicity in constant darkness (14), it seems that Bmal1 but not Clock is necessary for 
generation of circadian rhythmicity. Therefore, studying reproductive phenotype in 
Bmal1-/- mice may yield a better understanding of the impact of circadian rhythmicity and 
the molecular clock on reproduction. While the early stages of the reproductive process 
have been studied in Bmal1-/- females (15), examination of the late stages has not been 
possible due to infertility in these mice (15, 16).  
The SCN orchestrates circadian rhythmicity and entrains the molecular clocks 
present in peripheral tissues (4). The importance of these peripheral clocks is emerging. 
Tissue-specific roles for expression of Bmal1 in muscle (17) and retina (18) have been 
identified. Deletion of Bmal1 in specific peripheral tissues can circumvent the problem of 
infertility in conventional Bmal1-/- mice and facilitate the study of the role of Bmal1 and 
the importance of peripheral clocks in parturition. 
In the present report, we explore the role of Bmal1 in the myometrium for 
supporting successful parturition using a conditional Bmal1 knockout mouse line and a 
new myometrium and bladder specific Cre transgenic. We find that Bmal1 expression in 
the myometrium is important for timing of parturition and normal expression of 
contractile-associated proteins at the end of gestation. 
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Materials and Methods 
 
Animals 
 
Animals were maintained on a 12-h light, 12-h dark cycle with food and water available ad 
libitum. All animals used for experiments were 2-4 months of age. Females were mated to 
wild-type males. Morning of the plug was noted as d0.5 of gestation and the female was 
removed from the cage containing the male. On the C57BL/6 background, normal 
parturition occurs at d19.5 in our colony. Mice are known to deliver in the dark phase of the 
light:dark cycle. Therefore, we began monitoring parturition by checking the female’s cage 
for pups before lights out on d19.0 of gestation (ZT 11). The female’s cage was again 
checked after lights on at d19.5 of gestation (ZT 3). If parturition was not complete at this 
time, the female was checked a minimum of three times daily. Parturitions resulting in litters 
of 5-10 pups were included in analysis by chi-square test. P<0.05 was considered 
statistically significant. All animal experimentation described was conducted in accordance 
with accepted standards of humane animal care and was approved by the Washington 
University Animal Studies Committee/Vanderbilt University Insitutional Animal Care and 
Use Committee. 
Generation of conditional Bmal1 mice 
 
A bacterial artificial chromosome (BACPAC Resources, Children’s Hospital Oakland 
Research Institute) encompassing the Bmal1 gene was digested with EcoRV and BssHII 
and an 8.7 kb fragment containing the Bmal1 locus was subcloned into EcoRV/BssHII-
digested pBluescriptII+. A loxP site was inserted upstream of exon 2 into a unique AvrII 
site. A new BstEII site was created during this insertion. A cassette containing neomycin 
acetyltransferase (neo) flanked by two FRT sites and an additional loxP site was inserted 
into a unique BamHI site downstream of exon 4 to create the final construct. The 
linearized construct was electroporated into B6/Blu-1 ES cells. DNA from 167 G418 
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resistant ES cell clones was analyzed by Southern blot. Briefly, the DNAs were digested 
with EagI and BstEII and analyzed with probes flanking the region within the targeting 
vector. Four clones positive for targeted homologous recombination were identified. 
Karyotype analysis revealed an absence of chromosomal abnormalities in two of these 
clones. These clones were injected into C57BL/6 blastocysts using standard methods. 
After germline transmission was verified by Southern blot on tail DNAs, the neo cassette 
was removed by mating to transgenice mice expressing Flp recombinase under control of 
the Actin promoter (The Jackson Laboratory). Genotyping for presence of the conditional 
Bmal1 allele was performed using PCR with primers F: 5’-
GAACACAGAGGCTGGAGCTC-3’ and R: 5’-CTGTGATCCTCATACCCACG-3’. 
Conditional Bmal1 animals were bred to Actin-Cre mice (The Jackson Laboratory) for 
validation of function of the allele. In order to assess the efficiency of Bmal1 deletion, 
uterine and brain genomic DNAs were subjected to Southern blot hybridization. 
Generation of Telokin-Cre transgenic mice 
The construct used to generate Telokin-Cre transgenic mice was made from a 150 kb 
bacterial artificial chromosome encompassing the Telokin gene. An internal ribosome 
entry site followed by an eGFPcre FRT-flanked kanamycin cassette was inserted into the 
3’ UTR of the Telokin gene by homologous recombination. Positive kanamycin selection 
was used to identify incorporation of the Cre-containing cassette. The kanamycin cassette 
was then deleted by transformation of arabinose-inducible Flp-expressing EL250 bacteria 
(19). A final round of homologous recombination was used to delete a loxP site present in 
the sequence of the bacterial artificial chromosome. The DNA construct was then 
injected into C57BL/6 oocytes by standard methods. Two founders were obtained and 
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one was characterized extensively for expression of the transgene. Telokin-Cre+ mice 
were crossed with ROSA26 mice (The Jackson Laboratory) and Cre expression was 
evaluated by β-galactosidase staining on tissue sections following standard methods. 
Genotyping of Telokin-Cre mice was performed by PCR with primers 5’-
ATAGCTGGCTGGTGGCAGAT-3’ and 5’-TGCTTATAACACCCTGTTACG-3.’ 
Real-time qPCR 
For analysis of Bmal1 deletion, uterus was harvested from non-gravid, estrus stage 
females at ZT 4 (n=6-7 animals per genotype), snap frozen in liquid nitrogen, and stored 
at -80°C until processing. Total RNA was extracted from tissue samples using TriZol 
reagent (Invitrogen). RNA from individual samples was converted to cDNA using 
Quantitect Reverse Transcription Kit (Qiagen), which includes a step for elimination of 
genomic DNA. Bmal1 and Gapdh primers and real-time qPCR methods used were 
previously described (5). Gapdh was used for standardization. The ΔΔCt method was used 
for quantification (20). Statistical analysis was by Student’s t-test. Comparisons were 
considered statistically significant when P values were <0.05. 
Histological analysis  
Uterus was collected from non-gravid virgin females determined to be in estrus at ZT 13. 
Implantation sites were collected from gravid d16.0 females at ZT 13. Tissues were fixed in 
4% paraformaldehyde overnight, processed, and embedded in paraffin using standard 
protocols. Seven µm sections were cut. Sections were stained with hematoxylin and eosin or 
trichrome blue and examined with a light microscope. 
Progesterone measurements 
Non-gravid females determined to be in estrus and gravid females at d16.0 and d19.0 were 
euthanized with CO2 at ZT 13 and blood was collected by cardiac puncture. Serum was 
separated by centrifugation in heparanized tubes and stored at –80°C. Progesterone levels 
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were then assayed using solid-phase 125I-RIA according to manufacturer’s protocol 
(Diagnostic Products Corp., Los Angeles, CA). Statistical analysis was by two-way 
ANOVA. P<0.05 was considered statistically significant. 
Northern Hybridization Analyses 
In order to validate of disruption of Bmal1 in Bmal1 flox homozygous mice with global Cre 
expression, animals were sacrificed at ZT 4 and heart and brain were collected. For 
parturition studies, non-gravid estrus stage, d16.0, and d19.0 females were sacrificed at ZT 
13 and uterus was collected. Tissue was snap frozen in liquid N2 and stored at -80°C until 
processing. RNA was prepared using Trizol reagent (Invitrogen). Ten µg of total RNA for 
each sample were subjected to electrophoresis through agarose-formaldehyde gels and 
transferred to nitrocellulose membranes. Two Bmal1 riboprobes, one targeting the region of 
the gene floxed in the conditional allele and one targeting the 3’ region of the gene, were 
generated from GenBank NM_007489 nucleotides 734-1093 and 2324-2637, respectively. 
The Oxytocin receptor (Oxtr) riboprobe was generated from GenBank D86599 nucleotides 
432-1461. A plasmid containing a 1150 bp fragment of the Connexin43 (Cx43) coding 
region was a gift of Dr. Eric Beyer (University of Chicago) and was used to generate the 
Cx43 riboprobe. Antisense [α−32P]-labeled cRNA probes were generated from these 
templates using appropriate polymerases and hybridized to membranes. After washing, 
membranes were exposed to autoradiographic film and scanned at high resolution. 
Densitometric analysis was performed using National Institutes of Health Image software 
(Bethesda, MD). Each mRNA hybridization signal was corrected for loading and recovery 
by normalization to Cyclophilin A mRNA hybridization on the same filter. Statistical 
analysis was by two-way ANOVA and Student’s t-test. P<0.05 was considered statistically 
significant. 
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Results 
 
Myometrial-Specific Deletion of Bmal1 
 
To determine the role of Bmal1 in the myometrium during parturition, we generated a 
conditional Bmal1 knockout mouse. Exons 2-4 of Bmal1 are flanked by loxP sites 
(“floxed”) in this animal (Figure 1A). Exons 3 and 4 of Bmal1 encode the basic helix-
loop-helix (bHLH) domain which is necessary for heterodimerization of Bmal1 with 
Clock and DNA binding. In the presence of Cre recombinase this critical region is 
deleted in the conditional knockout animal. Targeted insertion of the floxed allele in the 
conditional Bmal1 knockout mice was confirmed by Southern blot (Figure 1B). 
In order to verify that Bmal1 is disrupted in the presence of Cre in our floxed 
Bmal1 mice, we generated animals homozygous for the floxed allele and positive for 
ubiquitously acting Actin-Cre. In these animals, Cre recombinase should excise the 
floxed region of Bmal1 in every tissue and the phenotype should resemble that of the 
conventional Bmal1-/- mice previously reported (14). Northern blot analysis was 
performed on heart and brain RNA from Bmal1-/- animals generated with the ubiquitously 
acting Cre and wild-type littermate controls. Two separate riboprobes were used. One 
riboprobe targets Bmal1 in the region floxed in our conditional knockout allele (Figure 
2A) and a second riboprobe targets the 3’ end of the Bmal1 transcript which is 
downstream of the floxed region in our allele (Figure 2B). Northern blot analysis using 
each of these Bmal1 riboprobes demonstrated efficient knockdown of Bmal1 transcript in 
Bmal1-/- animals generated using ubiquitously acting Cre. The efficacy of the conditional 
knockout allele was further validated by monitoring wheel-running activity in Bmal1 flox 
homozygous animals with or without Actin-Cre. In the absence of Actin-Cre, Bmal1 flox 
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homozygous animals were rhythmic in light:dark and dark:dark (Figure 2C). Mice 
homozygous for the floxed Bmal1 allele and positive for Actin-Cre were arrhythmic in 
dark:dark and displayed a lower level of activity overall (Figure 2D). This is similar to 
the wheel-running activity reported for previously generated Bmal1-/- mice (14). 
Expression of Telokin, the carboxy terminus of the smooth muscle myosin light 
chain kinase, is restricted to myometrium and other visceral smooth muscle sites (21, 22). 
Homologous recombination was used to generate Telokin-Cre transgenic mice. β-
galactosidase staining on sections from ROSA26 heterozygous; Telokin-Cre+ animals 
demonstrated robust expression of the transgene in myometrial layer of the uterus, but not 
in other tissues such as heart (Figure 3A). Expression was also noted in bladder, but 
absent in brain, kidney, liver, ovary, spleen, and skeletal muscle (data not shown).  
Having confirmed that our conditional knockout allele can be used to effectively 
delete Bmal1 and that the Telokin-Cre mice express Cre specifically in the myometrium, 
we generated mice homozygous for the floxed Bmal1 allele and positive for the Telokin-
Cre transgene. Southern blot analysis on uterus from these mice showed disruption of 
Bmal1 (Figure 3). The band representing the unrecombined allele which remains in 
uterus from mice of this genotype represents other cell types present in the uterus such as 
epithelium and stroma, where expression of the Telokin-Cre transgene is not expected. 
Analysis by real-time qPCR shows a 20% reduction in Bmal1 transcript in uterus of 
Bmal1 flox homo; Telokin-Cre+ mice versus Bmal1 flox homo; Telokin-Cre- littermates 
(P<0.05) (Figure 3), consistent with deletion of transcript in the myometrial portion of 
the uterus. The deletion of Bmal1 in the myometrium was not found to result in any gross 
anatomical changes in the uterus of either non-gravid estrus stage females (Figure 4A) or 
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pregnant females (Figure 4B). Differences in uterine thickness observed were within a 
normal range of variability. Furthermore, Bmal1 flox homo; Telokin-Cre+ mice were 
found to have normal fertility.  
Impaired parturition in females with disrupted myometrial Bmal1 
We monitored parturition in Bmal1 flox homo; Telokin-Cre+ females and littermate 
controls (Table 1). 93% of control females but only 64% of Bmal1 flox homo; Telokin-
Cre+ females completed parturition during the dark phase between d19.0 and d19.5 of 
gestation (P<0.05). One Bmal1 flox homo; Telokin-Cre+ female did not begin parturition 
until d22 of gestation and was sacrificed due to distress.  
Normal progesterone decline but altered contractile-associated protein expression at 
late gestation in females with disrupted myometrial Bmal1 
High levels of serum progesterone throughout gestation and a precipitous decline before 
the onset of parturition are characteristic of murine pregnancy (23). Serum progesterone 
levels were assayed in non-gravid estrus phase, gravid d16.0, and gravid d19.0 Bmal1 
flox homo; Telokin-Cre+ and Bmal1 flox homo; Telokin-Cre- littermate controls. A 
normal increase in serum progesterone at d16.0 and withdrawal at d19.0 were observed in 
the Bmal1 flox homo; Telokin-Cre+ females (Figure 5A). There were no significant 
differences in progesterone levels between Bmal1 flox homo; Telokin-Cre+and Bmal1 
flox homo; Telokin-Cre- littermate controls. Prior to parturition, the expression level of a 
cadre of contractile-associated proteins increases in the mouse and human myometrium 
(23). Expression of contractile-associated proteins Oxtr and Cx43 transcript were 
evaluated in uterus of non-gravid estrus phase, gravid d16.0, and gravid d19.0 Bmal1 flox 
homo; Telokin-Cre+ and Bmal1 flox homo Telokin-Cre- littermate controls. Expression of 
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Cx43 differed based on genotype (P<0.01, two-way ANOVA). Cx43 was significantly 
higher at d16.0 in Bmal1 flox homo; Telokin-Cre+ versus control uterus (P<0.05; 
Student’s t-test). Increased Cx43 expression in d19.0 Bmal1 flox homo; Telokin-Cre+ 
versus control uterus approached significance (P=0.08; Student’s t-test). No significant 
differences in uterine Oxtr expression between Bmal1 flox homo; Telokin-Cre+ and 
controls were observed. However, differences in Oxtr expression at d19.0 approached 
significance (P=0.14; Student’s t-test). 
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Discussion 
The importance of circadian rhythmicity and clock gene expression for normal resolution 
of pregnancy has been indicated by both human and rodent studies (1-3, 6, 7). Dissecting 
the roles of clock genes during late gestation is complicated by subfertility or infertility 
observed in genetically altered mice with clock gene deficiencies (15, 16, 24-26). Here, 
we use mice with a myometrium-specific disruption of Bmal1 to circumvent the problem 
of Bmal1-/- infertility and examine the role of Bmal1 in a tissue that plays a key role in 
parturition. We find that timing of labor and expression of contractile-associated proteins 
is altered in these females.  
While other conditional Bmal1 lines have been previously reported (18), we 
describe here for the first time utilization of a novel Telokin-Cre transgenic line. We 
demonstrate expression of this transgene specifically in the myometrial layer of the uterus 
(Figure 3A). Expression of the Telokin-Cre transgene was noted in bladder, but deletion 
in this tissue is not likely to affect the reproductive system. Deletion of uterine Bmal1 in 
Bmal1 flox homo; Telokin-Cre+ was demonstrated at the DNA level by Southern blot 
(Figure 3B) and at the RNA level by real-time qPCR (Figure 3C). These methods 
indicated a reduction and not an elimination of uterine Bmal1. This is expected due to the 
many different cell types besides myometrium found in the uterus. We attempted to 
demonstrate myometrium-specific deletion of BMAL1 on uterine sections from Bmal1 
flox homo; Telokin-Cre+ females with multiple commercially available BMAL1 
antibodies, but the antibodies were not suitably specific for this purpose. However, since 
β-galactosidase staining on uterine sections from ROSA26 heterozygous; Telokin-Cre+ 
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mice indicates that transgene expression is specific to the myometrial layer of the uterus 
(Figure 3A), deletion of Bmal1 should be restricted to the myometrium. 
All mammalian species examined demonstrate a propensity for delivery at a 
specific time of day. Mice deliver during the dark phase of a normal light:dark cycle, 
shortly before lights on. Females with disruption of myometrial Bmal1 were more likely 
than their littermate controls to labor outside of this normal time window, during the light 
phase (P<0.05). Bmal1 is a transcription factor (4) and many changes in gene expression 
in the myometrium are observed as parturition approaches (23). Therefore, it seemed 
likely that deletion of Bmal1 in the myometrium would result in altered expression of 
genes involved in parturition. We examined the expression profiles of known contractile-
associated proteins Cx43 and Oxtr in uterus of non-gravid, d16.0, and d19.0 Bmal1 flox 
homo; Telokin-Cre+ and Bmal1 flox homo; Telokin-Cre- littermate controls (Figure 
5B&C). Uterine Cx43 expression was found to differ by genotype (P<0.01; two-way 
ANOVA), with a significant increase in Cx43 at d16.0 (P<0.05; Student’s t-test) and a 
trend towards increased expression at d19.0 (P=0.08; Student’s t-test) in females with 
disruption of myometrial Bmal1. There was also a trend toward increased expression of 
Oxtr at d19.0 (P=0.14; Student’s t-test) in females with disruption of myometrial Bmal1. 
These increases in expression of Cx43 and Oxtr may contribute to the increased incidence 
of early start of parturition in myometrial Bma11 disrupted females. The effect of 
myometrial Bmal1 disruption on expression of these two genes was examined because of 
the genes’ known importance to parturition and myometrium-localized expression. 
Disruption of myometrial Bmal1 likely also alters expression of additional genes that 
contribute to the high incidence of both early and late labor.  
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This report indicates an importance of myometrium-specific expression of Bmal1 
in the timing of parturition. While altered expression patterns of Cx43 and Oxtr likely 
contribute to this phenotype, it is expected that changes in expression of additional genes 
downstream of Bmal1 also plays a role. Conditional Bmal1 mice can be used to explore 
possible roles of Bmal1 expression in additional peripheral tissues such as placenta and 
fetal membranes (5) in supporting the normal resolution of pregnancy. Furthermore, in 
this report we introduce the Telokin-Cre line which expresses Cre in the myometrial layer 
of the uterus. We expect that this line will be valuable for increasing the understanding of 
uterine biology in future studies.  
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Figure 2. Validation of floxed Bmal1 allele. Animals were sacrificed at ZT 4 and heart 
and brain were harvested. Northern blot used two different riboprobes targeting Bmal1 
transcript.  Bmal1 expression was analyzed using riboprobes targeting A) the floxed 
region and B) the 3’ end of the Bmal1 gene. Cyclophilin A expression on the same 
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per genotype.
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Figure 3. Specific disruption of Bmal1 using myometrium-specific Cre transgenic mouse. 
A) β-galactosidase staining of uterus and heart sections from ROSA26+/- mice that are 
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Figure 4. Normal uterine histology in females with myometrial Bmal1 disrupted. 
Paraffin sections of non-gravid uterus and whole implantation sites were stained 
with trichrome blue or hematoxylin and eosin and examined with a light microscope. 
A) Sections of non-gravid uterus from Bmal1 Flox Homo; Telokin-Cre- (top) and 
Bmal1 Flox Homo; Telokin-Cre+ (bottom) females. Panels on left are at 63X. Boxed 
area is shown to the right at 144X. Arrows indicate myometrial layers. e, endometrium; 
m, myometrium. B) Sections of whole implantation site from Bmal1 Flox Homo; 
Telokin-Cre- (top) and Bmal1 Flox Homo; Telokin-Cre+ (bottom) females. Implantation 
site panels on left are at 7X. Boxed area of uterus is shown on the right at 144X. 
Arrows indicate myometrial layers. p, placenta; b, fetal brain; l, fetal liver.
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Figure 5. Normal progesterone levels, but altered contractile-associated protein 
expression in females with disrupted myometrial Bmal1. Estrus stage non-gravid 
females and females of the day of gestation specified were sacrificed at ZT 13. 
Progesterone was assayed by solid-phase 125I-RIA. Cx43 and Oxtr expression 
were evaluated by Northern blot and standardized to Cyclophilin A expression. 
A) Serum progesterone levels (n=3, non-gravid and d19.0 for each genotype; 
n=7-8, d16.0 for each genotype). Values are means +SEM. B) Cx43 expression 
(n=3-4 per genotype per timepoint). Values are means +SEM. P<0.01 with respect 
to genotype; 2-way ANOVA. *P<0.05 vs. d16.0 Bmal1 Flox Homo, Telokin-Cre+; 
Student’s t-test. C) Oxtr expression (n=3-4 per genotype per timepoint). Values are 
means +SEM.
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(64%)
1 1
4 4*
*P<0.05 vs control normal labors by Chi-square test. 
Table 1. Parturition timing.
Bmal1 Flox Homo;
Tel-Cre-
Bmal1 Flox Homo;
Tel-Cre+
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The studies described in this thesis aimed to identify the role of the clock gene Bmal1 in 
the female reproductive system. The data demonstrate roles for Bmal1 in early and late 
stages of the reproductive process in females and suggest interesting areas for future 
research. 
 The work presented in Chapter Two explores the role of Bmal1 in female fertility. 
Bmal1 null mice are infertile. While follicle development, ovulation, fertilization, and 
preimplantation embryo development are observed in these females, implantation never 
occurs. This implantation defect results from an inability of the Bmal1 null females to 
produce the high levels of progesterone necessary at this stage of gestation. Low levels of 
the steroidogenesis enzyme StAR in corpora lutea of Bmal1 null females accompany this 
progesterone deficiency. 
 In addition to demonstrating implantation failure caused by impaired 
steroidogenesis in Bmal1 null females, these studies suggest the possibility of other 
fertility defects in these animals. Fewer oocytes appear to be ovulated in Bmal1 null 
females versus controls and fewer implantation sites per female are observed in 
progesterone supplemented Bmal1 null females versus control females. These 
observations may indicate abnormalities in the hormonal milieu that precipitates 
ovulation. Furthermore, while progesterone supplementation reinstitutes implantation in 
some Bmal1 null females, the incidence of implantation in supplemented Bmal1 null 
females does not reach that in unsupplemented controls. This may reflect roles for uterine 
Bmal1 in inducing expression of implantation related genes. Lastly, the implantation sites 
observed in progesterone supplemented Bmal1 null females have a significantly smaller 
diameter than those found in control females. This may indicate that implantation is 
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delayed in the progesterone supplemented Bmal1 null females and thus that these 
embryos are at an earlier stage of development, or that Bmal1 expression in the uterus is 
necessary for creating a normal environment for embryo growth. Further examination of 
these observed abnormalities may reveal additional roles for Bmal1 in the early stages of 
the reproductive process.  
 In addition to identifying a role for Bmal1 in female fertility, the work presented 
in Chapter Two adds to the emerging body of data indicating Bmal1 as an important 
regulator of steroidogenesis. Bmal1 has previously been demonstrated to regulate steroid 
hormone production through modulation of StAR expression in murine testis (1) and 
adrenal gland (2) as well as in preovulatory follicles of domestic poultry (3). Here, Bmal1 
is shown to be an important regulator of steroidogenesis in murine corpora lutea. 
 The work presented in Chapter Three aims to characterize clock gene expression 
in peripheral tissues that are key players in the later stages of reproduction. Recent 
studies indicate that clock gene expression in peripheral tissues can have important 
functions independent of SCN clock gene expression (4, 5). The data presented indicates 
the presence of the core clock genes in murine uterus, placenta, and fetal membranes 
during the last third of gestation. Interestingly, the expression of a subset of these genes 
increases in the final two days of gestation in each of these tissues. The timing of this 
induction is consistent with a possible role for these genes in regulating gene expression 
changes known to occur as parturition approaches. A subset of the examined clock genes 
display rhythmic transcript expression throughout the circadian day and bioluminescence 
studies indicate rhythmicity of PER2 protein in these tissues during day 16 of gestation. 
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This data suggests that functional peripheral molecular clocks are present in these tissues 
during late gestation.  
 These gene expression studies identify three peripheral tissues where clock genes 
may exert an impact on late gestation. Bmal1 conditional knockout mice were generated 
to explore possible roles for Bmal1 in these tissues during the late stages of the 
reproductive process. In Chapter Four, the role of myometrial Bmal1 expression in 
parturition is examined using these mice. The myometrium was selected for exploration 
because BMAL1 functions as a transcription factor and transcript of contractile 
associated proteins such as Prostaglandin F2α Receptor, Oxtr, and Cx43 is upregulated in 
the myometrium as parturition approaches (6). Mice normally deliver during the dark 
phase of the light:dark cycle; however, myometrial Bmal1 deficient females are more 
likely to deliver outside of the dark phase of the light:dark cycle than control females.  
This randomization of birth timing is accompanied by a disregulation of contractile 
associated protein expression. Increased expression of Cx43 and Oxtr in uterus of 
myometrial Bmal1 deficient females versus controls is noted during late gestation.  
Further investigation of the cause of randomization of birth timing in myometrial 
Bmal1 deficient females is likely to reveal other gene expression changes that contribute 
to the high incidence in both early and late labor observed. In addition, the Bmal1 
conditional knockout mice generated for use in these studies will be useful for future 
examination of the roles of Bmal1 in placenta, fetal membranes, or other portions of the 
uterus during late gestation.  
 The identification of the importance of Bmal1 for mammalian reproduction 
suggests that mutations in this gene may contribute to reproductive difficulties in women. 
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It may prove informative to determine whether women experiencing reproductive 
difficulties have a high incidence of mutations in Bmal1 or other clock genes. 
Furthermore, women affected by familial advanced sleep phase syndrome (FASPS) may 
be a relevant population for study. Men and women with FASPS experience early wake 
times and early sleep times (7). Mutations in Per2 and Casein kinase I δ , which 
phosphorylates PER2, have been shown to underlie this syndrome (7). Since Per2 is a 
regulator of Bmal1, it would be interesting to determine whether these females have a 
high incidence of reproductive difficulties.  
 A select group of regulatory mechanisms function at multiple points during the 
reproductive process. For example, cyclooxygenases and prostaglandins are critical for 
both implantation (8) and parturition (9). Furthermore, a luteotrophic role of oxytocin has 
been noted in mice along with its classically known role in parturition (10). Progesterone 
regulation functions in implantation (8) and is crucial for parturition in many organisms, 
possibly including humans (11). The work presented in this thesis adds Bmal1 to this list 
of regulators functioning at multiple points in the reproductive process. The conservation 
of other such regulators amongst species suggests the importance of Bmal1 and circadian 
rhythmicity to human reproduction.  
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